J1335 HCPCS Level II code: Injection, ertapenem sodium, 500 mg
J1335 is the HCPCS code for “Injection, ertapenem sodium, 500 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1335Injection, ertapenem sodium, 500 mg
Short description: Ertapenem injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J1335 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2004
Where J1335 sits
- 1J codesDrugs administered other than orally
- 2Active code J1335Injection, ertapenem sodium, 500 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1335 mean?
J1335 is the HCPCS code for “Injection, ertapenem sodium, 500 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1335?
CMS lists J1335’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1335
All J codesJ1323Injection, elranatamab-bcmm, 1 mgJ1324Injection, enfuvirtide, 1 mgJ1325Injection, epoprostenol, 0.5 mgJ1326Injection, zolbetuximab-clzb, 2 mgJ1327Injection, eptifibatide, 5 mgJ1330Injection, ergonovine maleate, up to 0.2 mgJ1364Injection, erythromycin lactobionate, per 500 mgJ1370Injection, esomeprazole sodium, 1 mgJ1380Injection, estradiol valerate, up to 10 mgJ1410Injection, estrogen conjugated, per 25 mgJ1411Injection, etranacogene dezaparvovec-drlb, per therapeutic doseJ1412Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes